AIV
68
-2
WU
32
2
SWN
82
2
GOOG
67
4
CPB
55
-2
EXPD
61
2
V
42
4
MA
64
4
VRSK
54
16
AN
57
5
FLS
63
-6
YUM
56
4
GM
55
3
XOM
48
6
KHC
56
6
AA
61
-2
CCI
49
16
CMCSA
59
2
KO
50
4
EQR
48
-2
AIV
68
-2
WU
32
2
SWN
82
2
GOOG
67
4
CPB
55
-2
EXPD
61
2
V
42
4
MA
64
4
VRSK
54
16
AN
57
5
FLS
63
-6
YUM
56
4
GM
55
3
XOM
48
6
KHC
56
6
AA
61
-2
CCI
49
16
CMCSA
59
2
KO
50
4
EQR
48
-2
Financhill
Back

Atara Biotherapeutics Vs. NovaBay Pharmaceuticals Industry Stock Comparison

Sell
20

ATRA
Atara Biotherapeutics

Last Price:
8.03
Seasonality Move:
-9.83%
Sell
49

NBY
NovaBay Pharmaceuticals

Last Price:
0.70
Seasonality Move:
-22.66%
Sell
20
Atara Biotherapeutics (ATRA) is a Sell

Is Atara Biotherapeutics a Buy, Sell or Hold?

  • The current Atara Biotherapeutics [ATRA] share price is $8.08. The Score for ATRA is 20, which is 60% below its historic median score of 50, and infers higher risk than normal.
  • ATRA is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
49
NovaBay Pharmaceuticals (NBY) is a Sell

Is NovaBay Pharmaceuticals a Buy, Sell or Hold?

  • The current NovaBay Pharmaceuticals [NBY] share price is $0.71. The Score for NBY is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.
  • NBY is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

ATRA Stock Price Chart

What is Atara Biotherapeutics's stock price today?

  • The Atara Biotherapeutics share price today is $8.08
    The current trend is relatively stagnant and ATRA is experiencing slight buying pressure.

NBY Stock Price Chart

What is NovaBay Pharmaceuticals's stock price today?

  • The NovaBay Pharmaceuticals share price today is $0.71
    The current trend is relatively stagnant and NBY is experiencing slight buying pressure.

ATRA Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.15 Sell
Relative Strength Index (14 RSI): 49.9 Sell
Chaikin Money Flow: 21080 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (7.13 - 8.91) Buy
Bollinger Bands (100): (7.24 - 13.32) Sell

NBY Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0 Buy
Relative Strength Index (14 RSI): 57.14 Buy
Chaikin Money Flow: 63291 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (0.44 - 0.64) Buy
Bollinger Bands (100): (0.44 - 3.24) Sell

ATRA Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 7.71 Buy
20-day SMA: 8.27 Sell
50-day SMA: 8.33 Sell
200-day SMA: 13.79 Sell
8-day EMA: 7.84 Buy
20-day EMA: 8.01 Buy
50-day EMA: 8.62 Sell
200-day EMA: 17.17 Sell

NBY Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 0.67 Buy
20-day SMA: 0.55 Buy
50-day SMA: 0.69 Buy
200-day SMA: 3.51 Sell
8-day EMA: 0.67 Buy
20-day EMA: 0.61 Buy
50-day EMA: 0.9 Sell
200-day EMA: 7.9 Sell

Atara Biotherapeutics Earnings Growth & ATRA Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.28 per share, an increase next quarter of $8.28 per share, an increase this year of $42.84 per share, and a decrease next year of $64.80 per share.

NovaBay Pharmaceuticals Earnings Growth & NBY Earnings Dates

  • Analysts estimate an earnings increase this quarter of $13.87 per share, an increase next quarter of $0.05 per share, an increase this year of $78.20 per share, and an increase next year of $1.81 per share.

Atara Biotherapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

NovaBay Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):